Global Bispecific Antibodies Market Size & Outlook, 2025-2031
Global Bispecific Antibodies Market Size
According to Straits Research analysis, the Global Bispecific Antibodies Market was valued at USD 5512.02 Million in 2024 and is projected to reach USD 14360.74 Million by 2031, expanding at a CAGR of 15.5% during the forecast period. Driving this growth is the escalating demand in industries such as healthcare and medicine, primarily for the treatment of various cancers and immune diseases. Bispecific antibodies also play a crucial part in agricultural applications, enhancing pest and disease resistance in crops. Emerging opportunities lie within green and sustainable production methods, underpinned by rapid technological advancements. Exports of these highly versatile antibodies are showing significant potential for global trade. As regions globally strive to consolidate their market position, the United States, in particular, is poised to become a substantial stakeholder in the global Bispecific Antibodies Market, leveraging its advanced biotechnological sector.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Bispecific Antibodies Market Highlights
- By segment, Bi-specific T-cell engager emerged as the largest Type in terms of market size in 2024.
- Bi-specific T-cell engager is anticipated to remain the most attractive Type segment, recording the fastest growth during the forecast period.
- In 2024, Global accounted for % of the global bispecific antibodies market size.
- By 2031, United States is expected to lead the global bispecific antibodies market in terms of market size.
- Within Global, Europe is projected to dominate the regional bispecific antibodies market size by 2031.
- Asia Pacific is identified as the fastest-growing market in Global, anticipated to reach USD 1475.55 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 5512.02 Million |
| Market Size In 2031 | USD 14360.74 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 15.5% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Global Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Region |
|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Global Bispecific Antibodies Market By Region 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
